BioSpace News Archive

Ikonopedia, a leading developer of an innovative cloud-based structured breast reporting and MQSA management system, today announced significant revenue growth for 2021 and first quarter 2022 at the annual Society of Breast Imaging (SBI) Symposium being held in Savannah, GA., May 16-19, 2022.

IONETIX, a leading cyclotron technology and isotope manufacturing company, is pleased to announce the FDA approval for N-13 Ammonia manufacturing at their Miami, FL location to support CIRA.

Limaca Medical and HekaBio K.K. announced that they have inked a strategic partnership agreement, whereby HekaBio is to distribute Limaca’s Precision-GI™ Endoscopic Biopsy Device in Japan.

Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today presented new preclinical data showing that silencing BRD4 with PH-894, a self-delivering RNAi INTASYL compound, can be used to improve the characteristics of CAR-T cell products during the activation and expansion phases of the cell manufacturing process.

Promontory Therapeutics Inc. , a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, today announced the appointment of Johan Baeck, MD, as Executive Vice President and Chief Medical Officer.

Commercialization of Accelerate Arc system, which includes the Accelerate Arc Module and BC kit, unlocks the path to automated, rapid microbial ID for positive blood cultures across the large installed base of MALDI system users.

Altoida announced it has joined the Digital Medicine Society’s Alzheimer’s Disease and Related Dementias Digital Measures Development Project to support the advancement of its precision neuro-biomarkers platform.

RootPath announced that a poster presentation highlighting its lead therapeutic candidates, a series of fully personalized T cell therapies, at the American Society of Gene & Cell Therapy 25th Annual Meeting taking place May 16-19, 2022 in Washington, D.C.

The PPD clinical research business of Thermo Fisher Scientific has been recognized for excellence in the 2022 CRO Leadership Awards.

Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for cancer treatment, today announced the appointment of Steve Sabus as Chief Commercial Officer, effective as of May 31, 2022.